Senior Clinical Research Associate

Senior Clinical Research Associate (CRA)

Contract

United States

Oncology | Phase I to III Studies

We are supporting an innovative and well-funded biotechnology company as they continue to expand their clinical development activities across a growing oncology portfolio.

Due to ongoing study growth, we are seeking experienced Senior Clinical Research Associates to support Phase I to III oncology trials across the United States.

This is an opportunity to join a highly collaborative clinical team working on cutting-edge therapies with the potential to make a meaningful impact on patient outcomes.

Key Responsibilities

• Conduct Site Evaluation Visits, Site Initiation Visits, Interim Monitoring Visits and Close Out Visits

• Oversee assigned investigative sites to ensure patient safety, protocol compliance and data quality

• Review source documentation and case report forms

• Ensure studies are conducted in accordance with ICH GCP, FDA regulations and company SOPs

• Build and maintain strong relationships with investigators and site personnel

• Identify and escalate site risks and support resolution activities

• Support inspection readiness and study audit activities where required

• Collaborate with Clinical Trial Managers, Clinical Operations and cross-functional study teams

• Prepare monitoring reports and maintain accurate study documentation

Requirements

• Bachelor's degree in Life Sciences or a related discipline

• Previous experience working as a CRA or Senior CRA within biotechnology, pharmaceutical or CRO environments

• Strong oncology clinical trial experience

• Experience monitoring Phase I, Phase II and Phase III studies

• Excellent knowledge of ICH GCP and FDA regulations

• Ability to work independently while managing multiple sites and priorities

• Strong communication and relationship-building skills

• Experience with site start-up, maintenance and close-out activities

Preferred Experience

• Early phase oncology studies

• Immuno-oncology experience

• First-in-human studies

• Solid tumour and haematology experience

• Sponsor-side experience

Why Consider This Opportunity?

• Join a rapidly growing biotechnology organisation

• Work on innovative oncology programmes

• Highly visible role within the clinical team

• Collaborative and science-driven culture

• Long-term contract potential

• Competitive hourly rates

• Opportunity to contribute directly to the advancement of novel cancer therapies

Applications are being reviewed immediately, and interviews are expected to commence shortly.